Benzenesulfonamide, N-[4'-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)methyl][1,1'-biphenyl]-4-yl]-4-methoxy-N-[(4-methoxyphenyl)sulfonyl]-

Benzenesulfonamide, N-[4'-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)methyl][1,1'-biphenyl]-4-yl]-4-methoxy-N-[(4-methoxyphenyl)sulfonyl]- Suppliers list
Company Name: Shandong Dayou Pharmaceutical Research and Development Co., Ltd.  
Tel: hanfangpharma@126.com 15165037910
Email: hanfangpharma@126.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Company Name: TargetMol Chemicals Inc.  
Tel: 13564774135
Email: marketing@targetmol.com

Benzenesulfonamide, N-[4'-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)methyl][1,1'-biphenyl]-4-yl]-4-methoxy-N-[(4-methoxyphenyl)sulfonyl]- manufacturers

Benzenesulfonamide, N-[4'-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)methyl][1,1'-biphenyl]-4-yl]-4-methoxy-N-[(4-methoxyphenyl)sulfonyl]- Basic information
Product Name:Benzenesulfonamide, N-[4'-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)methyl][1,1'-biphenyl]-4-yl]-4-methoxy-N-[(4-methoxyphenyl)sulfonyl]-
Synonyms:Benzenesulfonamide, N-[4'-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)methyl][1,1'-biphenyl]-4-yl]-4-methoxy-N-[(4-methoxyphenyl)sulfonyl]-;P-gp inhibitor 4
CAS:2652001-05-1
MF:C38H38N2O8S2
MW:714.85
EINECS:
Product Categories:
Mol File:2652001-05-1.mol
Benzenesulfonamide, N-[4'-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)methyl][1,1'-biphenyl]-4-yl]-4-methoxy-N-[(4-methoxyphenyl)sulfonyl]- Structure
Benzenesulfonamide, N-[4'-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)methyl][1,1'-biphenyl]-4-yl]-4-methoxy-N-[(4-methoxyphenyl)sulfonyl]- Chemical Properties
Boiling point 838.3±75.0 °C(Predicted)
density 1.313±0.06 g/cm3(Predicted)
pka6.97±0.20(Predicted)
Safety Information
MSDS Information
Benzenesulfonamide, N-[4'-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)methyl][1,1'-biphenyl]-4-yl]-4-methoxy-N-[(4-methoxyphenyl)sulfonyl]- Usage And Synthesis
UsesP-gp inhibitor 4 (Compound 8b) is a selective P-glycoprotein modulator with an EC50 of 94 nM. P-gp inhibitor 4 increases agent transport across gastro-intestinal barrier and recovers doxorubicin toxicity in multidrug resistant cancer cells[1].
References[1] Contino M, et al. One molecule two goals: A selective P-glycoprotein modulator increases drug transport across gastro-intestinal barrier and recovers doxorubicin toxicity in multidrug resistant cancer cells. Eur J Med Chem. 2020 Dec 15;208:112843. DOI:10.1016/j.ejmech.2020.112843
Benzenesulfonamide, N-[4'-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)methyl][1,1'-biphenyl]-4-yl]-4-methoxy-N-[(4-methoxyphenyl)sulfonyl]- Preparation Products And Raw materials
Tag:Benzenesulfonamide, N-[4'-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)methyl][1,1'-biphenyl]-4-yl]-4-methoxy-N-[(4-methoxyphenyl)sulfonyl]-(2652001-05-1) Related Product Information
Benzenesulfonamide, N-[4'-[(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)methyl][1,1'-biphenyl]-4-yl]-4-methoxy-N-[(4-methoxyphenyl)sulfonyl]- DEOXYNIVALENOL (2R)-1-{4-[(1aR,6r,10bS)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]piperazin-1-yl}-3-(quinolin-5-yloxy)propan-2-ol Piperine Muscone (E)-3-[[[3-[2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-[[(3-dimethylamino)-3-oxopropyl]thio]methyl]thio]-propanoic acid, sodium salt